This RPP is being issued by the Defense Health Agency Contracting Activity (DHACA), in support of the Defense Health Agency’s Portfolio Acquisition Executive (PAE) Medical Products (MP) Warfighter Protection (WPAC) & Acute Care Program Management Office (PMO) Care located in Frederick, Maryland at Fort Detrick. The Warfighter Protection and Acute Care Project Management Office (WPAC PMO) has a requirement for the development of a Barrier Combination product. The Barrier Combination product is defined as being composed of both a physical barrier to protect a wound and an antibacterial and/or antifungal activity released from the barrier to prevent the spread of organisms and avoid systemic infections.
This RPP will result in one award to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product.
The final product MUST be a combination wound treatment that includes a barrier component that is either infused or impregnated with antimicrobial and/or antifungal properties and have U.S. Food Drug Administration (FDA) approval (or clearance).
The award, as a result of this RPP, will be awarded under the authority of prototype Other Transaction Authority (pOTA) 10 U.S.C. 4022.
The scope includes all activities required to develop the Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination (BC) prototype product and achieve FDA approval or clearance. Work is divided into three objectives: Objective 1 (24 months) involves demonstrating a working prototype with antimicrobial activity and completing preclinical testing to support an IND or IDE application. Objective 2 (24 months) involves executing clinical studies to demonstrate safety and efficacy in humans, establishing Chemistry, Manufacturing, and Controls (CMC), and delivering up to 50 final design prototypes. Objective 3 (6 months) involves delivering notice of FDA clearance or approval. The final product must meet a Technology Readiness Level (TRL) 7 at submission to FDA and TRL 8 upon approval. Required attributes include a minimum 12-month shelf-life, prevention of bacterial infection, and barrier integrity for at least 24 hours.
We post new food & catering opportunities in Maryland as agencies publish them. Get them in one email — free, and unsubscribe whenever.
"HT9427-26-R-E020-RPP for BWI-PT-Barrier (pOTA).pdf"387646"file"".pdf""1""2026-09-23T13:01:05.028+00:00""1a347efdee7b4b17a4854d0256977d30""public""0""public""f386347c30c64f7eb00bcbdaf18f170a""0"85"0""Attachment A - Statement of Objectives (SOO).pdf"193816"file"".pdf""1""2026-09-23T13:01:05.028+00:00""6dfd7849960e40af92d36b06742e34ec""public""0""public""49cadd882b8647f19820cfb47d4938f9""0"73"0""Attachment B - Contract Data Requirements List (CDRL).pdf"55381"file"".pdf""1""2026-09-23T13:01:05.028+00:00""56fda265b93f49819dc8ce4d8d6b7d82""public""0""public""b4be112bf66548b1bbc24fc7487c6723""0"61"0""Attachment C - Data Item Description (DID) DI-TCSP-82040 (REFERENCE ONLY).pdf"361706"file"".pdf""1""2026-09-23T13:01:05.028+00:00""9dd9960b10064a73876cbe905c920320""public""0""public""5f5e8c6da66240878054ea9106527dff""0"50"0""Attachment D1 - FDA Form 1571.pdf"396983"file"".pdf""1""2026-09-23T13:01:05.028+00:00""4ce50289d4214e12b6f811bb6d897f9c""public""0""public""4c79bab19e7647998b4af3af09048fd1""0"40"0""Attachment D2 - FDA Form 1571 Instructions (REFERENCE ONLY).pdf"350373"file"".pdf""1""2026-09-23T13:01:05.028+00:00""4616ecc4a869449e9d76da48c1e03eb6""public""0""public""494b6d55579c485fa5092492ba9b2eb6""0"31"0""Attachment E - Draft Agreement Terms and Conditions.pdf"799610"file"".pdf""1""2026-09-23T13:01:05.028+00:00""b8df36619dcb469ebb13d037ca47072f""public""0""public""87390c69f5cd460d8cb0fc37b069f7d5""0"23"0""Attachment F - Warranties and Representatives.docx"30492"file"".docx""1""2026-09-23T13:01:05.028+00:00""935d5ff023a84a789470b34129c53e1b""public""0""public""b1407f0d9b284ddca96f5d8a990265a6""0"17"0""Attachment G1 - Cost Sheet Template.xlsx"161997"file"".xlsx""1""2026-09-23T13:01:05.028+00:00""ca5ddef646c6477b9b78524e3e7dfacb""public""0""public""22912abb5dc84f97b619913a0a4bfe33""0"15"0""Attachment G2 - Firm Fixed Price Sheet Template.xlsx"146157"file"".xlsx""1""2026-09-23T13:01:05.028+00:00""470679e074d94d5f9fb03c20c9db6cec""public""0""public""75588cd5f0ff4296995929370ffd22b8""0"13"0""Attachment H - Statement of Work Template (see Section 11).docx"62337"file"".docx""1""2026-09-23T13:01:05.028+00:00""f6417f8eb8f44a9484cfa36d6fb22006""public""0""public""ceb7fb45cc974d30ba8644862e923d38""0"12"0""Attachment I1 - Technology Readiness Level (TRL) for drug and biologics (REFERENCE ONLY).pdf"246456"file"".pdf""1""2026-09-23T13:01:05.028+00:00""0e3fe606f34f47a8a0ee89f9e816199b""public""0""public""098577afbbef488eb3e9c4b1cfddcd7d""0"11"0""Attachment I2-Technology Readiness Level (TRL) for diagnostics and devices (REFERENCE ONLY).pdf"275706"file"".pdf""1""2026-09-23T13:01:05.028+00:00""0f19b1b218404f6283a9918fdb049475""public""0""public""d0a14a6e6e0f427a8661307b087ea46e""0"10"0""Attachment J - Offeror question form.xlsx"11408"file"".xlsx""1""2026-09-23T13:01:05.028+00:00""4c540e10784143468bd94e4403ec9682""public""0""public""be1e10b4f09140c78a4680f7738d976b""0"9"0"Most Maryland work asks for the two below, and the solicitation documents are where it’s stated. One prequalification covers both — on this bid and the next.
A surety’s written statement that it expects to bond you up to a stated amount, subject to final underwriting. It’s what an agency asks to see before they take your bid seriously.
Source: SAM.gov (notice 93963f59cd0a4b8eb1faa2e99cc77c36), retrieved via the SAM.gov Get Opportunities API. View the official posting, and always confirm requirements and deadlines with the issuing agency.